Jeff

Equibles does not estimate personal net worth.

About Jeff

Jeff has spoken on 1 investor event across 1 company, most recently for Corvus Pharmaceuticals, Inc. on June 8, 2026. Corvus Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Corvus Pharmaceuticals, Inc. includes Richard Miller (CEO and Board Member), Leiv Lea (CFO), Andrew C. Chan, M.D., Ph.D. (Board Member) and 6 others.

Jeff on recent calls

“Yeah, so maybe I can give a little bit of an overview of the company and talk about some of our competencies and priorities. So Corvus is a clinical stage company.”

Other, Goldman Sachs 47th Annual Global Healthcare Conference · June 8, 2026